In vitro activity of telithromycin against Streptococcus pneumoniae resistant to other antibiotics, including cefotaxime

被引：11

作者：

Fuchs, PC ^{[1
]}

Barry, AL ^{[1
]}

Brown, SD ^{[1
]}

机构：

[1] Inst Clin Microbiol, Wilsonville, OR 97070 USA

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 49卷 / 02期

关键词：

D O I：

10.1093/jac/49.2.399

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

A total of 407 isolates of Streptococcus pneumoniae, most of which were resistant to one or more antibiotics, were tested for susceptibility to telithromycin and four other agents. Telithromycin was the most active agent tested, with 98% of isolates susceptible to less than or equal to1.0 mg/L. For strains resistant to the other antibiotics, susceptibility to telithromycin ranged from 98.6% for strains resistant to trimethoprim/sulfamethoxazole to 94.4% for strains resistant to cefotaxime.

引用

收藏

页码：399 / 401

页数：3

相关论文

共 10 条

[1]

[Anonymous], 1996, MMWR Recomm Rep, V45, P1

[2] Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin) [J].

Barry, AL ;

Fuchs, PC ;

Brown, SD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) :945-946

[3] Emergence of a high-level cefotaxime-resistant Streptococcus pneumoniae strain in New Zealand [J].

Brett, MS .

JOURNAL OF MEDICAL MICROBIOLOGY, 2001, 50 (02) :173-176

[4] Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999:: Prevalence of mef(A) and erm(B) and susceptibilities to ketolides [J].

Hoban, DJ ;

Wierzbowski, AK ;

Nichol, K ;

Zhanel, GG .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) :2147-2150

[5] In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998 [J].

Jones, RN ;

Jenkins, SG ;

Hoban, DJ ;

Pfaller, MA ;

Ramphal, R .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 37 (02) :93-98

[6] Activities of antimicrobial agents against intracellular pneumococci [J].

Mandell, GL ;

Coleman, EJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2561-2563

[7]

National Committee for Clinical Laboratory Standards, 2000, M7A5 NCCLS

[8] Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents [J].

Pankuch, GA ;

Visalli, MA ;

Jacobs, MR ;

Appelbaum, PC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) :624-630

[9]

Wong S. S. Y., 1999, Hong Kong Medical Journal, V5, P406

[10] Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae:: Results of a Canadian national surveillance study [J].

Zhanel, GG ;

Karlowsky, JA ;

Palatnick, L ;

Vercaigne, L ;

Low, DE ;

Hoban, DJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (10) :2504-2509